Chapter 17 – Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path

Multiple sclerosis (MS) is predominantly considered an immune-mediated chronic disease, with complicated pathogenesis and clinical signs of paralysis. MS is an inflammatory disease of the central nervous system in which T lymphocytes show a second phase of activation. This activation is followed by axonal demyelination and neurological disorder manifestations. In most patients, the disease is associated with axonal loss and progressive disabilities.